We are pleased to announce that on October 30, 2025, EngiTissue Design Co., Ltd. carried out a capital increase through the issuance of new shares, raising its stated capital to 61,351,300 yen.
This raised the company’s capital from the 10,000,000 yen recorded at the time of incorporation. The details are as follows.
- Effective date: October 30, 2025
- Stated capital after the increase: 61,351,300 yen
- Total number of issued shares after the increase: 1,114 shares
The funds raised through this capital increase will be used to advance the research and development of our iPSC-derived organoid and 3D tissue platforms and to strengthen our business structure. We sincerely appreciate your continued support.